JP2007517826A5 - - Google Patents

Download PDF

Info

Publication number
JP2007517826A5
JP2007517826A5 JP2006548231A JP2006548231A JP2007517826A5 JP 2007517826 A5 JP2007517826 A5 JP 2007517826A5 JP 2006548231 A JP2006548231 A JP 2006548231A JP 2006548231 A JP2006548231 A JP 2006548231A JP 2007517826 A5 JP2007517826 A5 JP 2007517826A5
Authority
JP
Japan
Prior art keywords
alkyl
independently hydrogen
independently
membered ring
attached
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006548231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007517826A (ja
JP4533391B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/000095 external-priority patent/WO2005067933A1/en
Publication of JP2007517826A publication Critical patent/JP2007517826A/ja
Publication of JP2007517826A5 publication Critical patent/JP2007517826A5/ja
Application granted granted Critical
Publication of JP4533391B2 publication Critical patent/JP4533391B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2006548231A 2004-01-16 2005-01-07 中枢神経系疾患の処置のための5−ヒドロキシトリプタミンレセプター(5−ht)のモジュレーターとしての、1−ベンジル−5−ピペラジン−1−イル−3,4−ジヒドロ−1h−キナゾリン−2−オン誘導体、ならびにそれぞれの1h−ベンゾ(1,2,6)チアジアジン−2,2−ジオキシドおよび1,4−ジヒドロベンゾ(d)(1,3)オキサジン−2−オン誘導体 Expired - Fee Related JP4533391B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53708004P 2004-01-16 2004-01-16
PCT/EP2005/000095 WO2005067933A1 (en) 2004-01-16 2005-01-07 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system

Publications (3)

Publication Number Publication Date
JP2007517826A JP2007517826A (ja) 2007-07-05
JP2007517826A5 true JP2007517826A5 (US07714131-20100511-C00001.png) 2008-08-28
JP4533391B2 JP4533391B2 (ja) 2010-09-01

Family

ID=34794441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006548231A Expired - Fee Related JP4533391B2 (ja) 2004-01-16 2005-01-07 中枢神経系疾患の処置のための5−ヒドロキシトリプタミンレセプター(5−ht)のモジュレーターとしての、1−ベンジル−5−ピペラジン−1−イル−3,4−ジヒドロ−1h−キナゾリン−2−オン誘導体、ならびにそれぞれの1h−ベンゾ(1,2,6)チアジアジン−2,2−ジオキシドおよび1,4−ジヒドロベンゾ(d)(1,3)オキサジン−2−オン誘導体

Country Status (19)

Country Link
US (2) US7196087B2 (US07714131-20100511-C00001.png)
EP (1) EP1708713B1 (US07714131-20100511-C00001.png)
JP (1) JP4533391B2 (US07714131-20100511-C00001.png)
KR (1) KR100843053B1 (US07714131-20100511-C00001.png)
CN (1) CN1909909B (US07714131-20100511-C00001.png)
AR (1) AR047958A1 (US07714131-20100511-C00001.png)
AT (1) ATE388712T1 (US07714131-20100511-C00001.png)
AU (1) AU2005205016B2 (US07714131-20100511-C00001.png)
BR (1) BRPI0506909A (US07714131-20100511-C00001.png)
CA (1) CA2552681A1 (US07714131-20100511-C00001.png)
CO (1) CO5700763A2 (US07714131-20100511-C00001.png)
DE (1) DE602005005298T2 (US07714131-20100511-C00001.png)
ES (1) ES2302174T3 (US07714131-20100511-C00001.png)
IL (1) IL176631A0 (US07714131-20100511-C00001.png)
NO (1) NO20062791L (US07714131-20100511-C00001.png)
RU (1) RU2006129464A (US07714131-20100511-C00001.png)
TW (1) TW200530222A (US07714131-20100511-C00001.png)
WO (1) WO2005067933A1 (US07714131-20100511-C00001.png)
ZA (1) ZA200605434B (US07714131-20100511-C00001.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4975626B2 (ja) * 2004-09-30 2012-07-11 エフ.ホフマン−ラ ロシュ アーゲー 認知障害の処置用の組成物および方法
US7713954B2 (en) * 2004-09-30 2010-05-11 Roche Palo Alto Llc Compositions and methods for treating cognitive disorders
AU2005316739A1 (en) * 2004-12-13 2006-06-22 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
EP1904483A1 (en) * 2005-07-13 2008-04-02 F. Hoffmann-Roche AG Benzimidazole derivatives as 5-ht6,5-ht24
KR100817538B1 (ko) * 2006-07-05 2008-03-27 한국화학연구원 신규 치환된―1h―퀴나졸린―2,4―디온 유도체, 이의제조방법 및 이를 함유하는 약학적 조성물
KR20090107994A (ko) * 2006-09-11 2009-10-14 엔.브이.오가논 퀴나졸리논 및 이소퀴놀리논 아세트아미드 유도체
WO2008073958A2 (en) 2006-12-12 2008-06-19 Wyeth Substituted benzothiadiazinedioxide derivatives and methods of their use
MX2010014394A (es) * 2008-06-20 2011-05-19 Rottapharm Spa Derivados de 6-1h-imidazo-quinazolina y quinolinas, nuevos inhibidores de monoamina oxidasa y ligandos del receptor de imidazolina.
KR20110038180A (ko) * 2008-09-08 2011-04-13 에프. 호프만-라 로슈 아게 5-치환된 벤즈옥사진
EP2592083A4 (en) 2010-05-21 2014-01-22 Shenzhen Salubris Pharm Co Ltd CONDENSED QUINAZOLINE DERIVATIVES AND USES THEREOF
IL291029B2 (en) * 2016-11-15 2024-06-01 Univ Temple New modulators of 5-hydroxytryptamine receptor 7 and a method of using them
CA3154630A1 (en) * 2019-10-21 2021-04-29 Mark E. Duggan 3-(4-(11h-dibenzo[b,e][1,4]azepin-6-yl)piperazin-1-yl)- and 3-(4-(dibenzo[b,f][1,4]oxazepin/thiazepin/diazepin-11-yl)piperazin-1-yl)-propano ic acid derivatives as h1 and 5-ht2a-receptor modulators for the treatment of sleep disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642791A (en) 1969-08-13 1972-02-15 Sandoz Ag Morpholino-1-substituted-2(1h)-quinazolinones
JPS5271483A (en) 1975-12-11 1977-06-14 Sumitomo Chem Co Ltd Synthesis of 2(1h)-quinazolinone derivatives
CN1015459B (zh) * 1985-06-06 1992-02-12 田边制药株式会社 喹唑啉酮化合物的制备方法
GR1000821B (el) * 1988-11-22 1993-01-25 Tanabe Seiyaku Co Μεθοδος παραγωγης παραγωγων κιναζολινονης.
WO1998018781A2 (en) 1996-10-28 1998-05-07 Versicor, Inc. Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
WO1998042688A1 (fr) 1997-03-26 1998-10-01 Sumitomo Pharmaceuticals Co., Ltd. Derives de 4-arylmethylene-1,4-dihydro-2h-azine
AU9503998A (en) 1997-10-28 1999-05-17 Warner-Lambert Company Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents
WO1999037643A1 (fr) * 1998-01-26 1999-07-29 Yamanouchi Pharmaceutical Co., Ltd. Nouveaux derives heterocycliques a fusion benzenique ou sels de ceux-ci
WO2001032626A1 (en) * 1999-11-05 2001-05-10 Smithkline Beecham P.L.C. Isoquinoline and quinazoline derivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity
AU1626001A (en) 1999-11-23 2001-06-04 Smithkline Beecham Corporation 3,4-dihydro-(1h)-quinazolin-2-ones and their use as csbp/p38 kinase inhibitors
AU2525701A (en) 1999-12-14 2001-06-25 Sanofi-Synthelabo Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses
CA2431904A1 (en) * 2000-12-20 2002-08-01 Merck & Co., Inc. (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
US6998408B2 (en) 2001-03-23 2006-02-14 Bristol-Myers Squibb Pharma Company 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
JP2005501019A (ja) * 2001-06-15 2005-01-13 エフ.ホフマン−ラ ロシュ アーゲー 5−ht6レセプター親和性を有する4−ピペラジニルインドール誘導体
GB0203804D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
ATE316523T1 (de) * 2002-05-13 2006-02-15 Hoffmann La Roche Benzoxazinderivate als 5-ht6-modulatoren und deren verwendungen

Similar Documents

Publication Publication Date Title
JP2007517826A5 (US07714131-20100511-C00001.png)
JP2019104748A5 (US07714131-20100511-C00001.png)
JP2007508359A5 (US07714131-20100511-C00001.png)
JP2010504286A5 (US07714131-20100511-C00001.png)
JP2008546770A5 (US07714131-20100511-C00001.png)
JP2006528646A5 (US07714131-20100511-C00001.png)
JP2009515988A5 (US07714131-20100511-C00001.png)
JP2007518682A5 (US07714131-20100511-C00001.png)
JP2013504593A5 (US07714131-20100511-C00001.png)
JP2007508362A5 (US07714131-20100511-C00001.png)
JP2011521911A5 (US07714131-20100511-C00001.png)
JP2013510178A5 (US07714131-20100511-C00001.png)
JP2007534702A5 (US07714131-20100511-C00001.png)
JP2009516727A5 (US07714131-20100511-C00001.png)
JP2007246474A5 (US07714131-20100511-C00001.png)
JP2010535722A5 (US07714131-20100511-C00001.png)
JP2007523941A5 (US07714131-20100511-C00001.png)
JP2005510476A5 (US07714131-20100511-C00001.png)
JP2010501478A5 (US07714131-20100511-C00001.png)
JP2007503487A5 (US07714131-20100511-C00001.png)
EA201070873A1 (ru) Производные n-азабициклических карбоксамидов, их получение и применение в терапии
JP2009532878A5 (US07714131-20100511-C00001.png)
JP2011525509A5 (US07714131-20100511-C00001.png)
WO2009112678A3 (fr) Derives de carboxam i d es azabicycliques, leur preparation et leur application en therapeutique.
JP2008545801A5 (US07714131-20100511-C00001.png)